Nursing Care With Patients With Venous Leg Ulcers

Status Unknown status

Clinical Trial Summary

Aims are:

- develop an Internet-based education programme about venous leg ulcer nursing care (ELC)

- evaluate the clinical, cognitive and economical outcomes of education programme

Research questions are:

1. What are the cognitive outcomes of ELC (perceived knowledge, attitudes towards venous leg ulcer nursing care, theoretical knowledge level and practical knowledge)?

Hypotheses for research question 1 are:

1. Nurses using the ELC will have better knowledge (perceived, practical and theoretical knowledge) than those who will not use the ELC.

2. Nurses using the ELC will have more positive attitudes towards venous leg ulcer nursing care than those who will not use the ELC.

2. What are the clinical outcomes of ELC (ulcer healing, ulcer size, treatment supplies)?

Hypotheses for research question 2 are:

1. Ulcer healing progresses better among patients who are taken care by nurses using the ELC.

2. Ulcer sizes will be 10 % smaller among the patients cared for nurses using the ELC.

3. Nurses using the ELC will use mire adequate treatment supplies than those who will not use the ELC.

3. What are the economical outcomes (treatment time and supply usage) of ELC?

Hypothesis for research question 3 is:

1. The economical expenditures will be lower among nurses using the ELC.

The ultimate aim is to promote evidence-based nursing care among patients with venous leg ulcer.

Clinical Trial Description

The study takes place in home-care in two Finnish municipality, which are similar size and staff structure and working ideology are basically the same.

Enrolment of participants has started with information occasion in both municipalities in June 2014. Nurses were asked to fill the Patients Clinical Situation Questionnaire, handouts and forms for informed consent were delivered. (Figure 1) All eligible nurses and patients will be identified with Patient Clinical Assessment. The sample size was determined with power analysis and the result was that 200 nurses are needed in the intervention group and 100 nurses in the comparison group. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02224300
Study type	Interventional
Source	University of Turku
Contact	Minna S Ylönen, PhD-candidate
Phone	+358400667809
Email	misuyl@utu.fi
Status	Unknown status
Phase	Phase 2
Start date	August 2014
Completion date	December 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00663091` - A Prospective, Randomized, Double-Blind Controlled Study of WPP-201 for the Safety and Efficacy of Treatment of Venous Leg Ulcers	Phase 1
Recruiting	`NCT02609594` - Amnioband and Standard of Care vs. Standard of Care Alone in the Treatment of Venous Leg Ulcers	N/A
Unknown status	`NCT02011724` - A Study Of Pain And Quality Of Life Outcomes In Subjects With a Single Painful Venous Leg Ulcer Treated With Apligraf®	Phase 4
Active, not recruiting	`NCT01737762` - Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2	Phase 3
Completed	`NCT02222467` - Safety Evaluation of the KLOX BioPhotonic System in Venous Leg Ulcers	N/A
Completed	`NCT01199588` - A Study to Investigate the Efficacy, Safety and Tolerability of Nexagon® as a Topical Treatment for Subjects With Venous Leg Ulcers	Phase 2
Withdrawn	`NCT00953563` - The Mechanism of Action of Unite Biomatrix in Venous Leg Ulcers	N/A
Enrolling by invitation	`NCT02047084` - Comparison of Human Allograft to Apligraf for Venous Leg Ulcers
Completed	`NCT02020746` - Efficacy and Safety Study of EscharEx to Treat (Debride) Hard to Heal Wounds	Phase 2
Terminated	`NCT02154087` - A Phase 2 Exploratory Pharmacodynamic Study of HP802-247 in Venous Leg Ulcers	Phase 2
Completed	`NCT02470806` - Single-Use Negative Pressure Wound Therapy System vs. Traditional Negative Pressure Wound Therapy System (tNPWT)	N/A
Suspended	`NCT02577120` - Wound Healing Endpoint and Recurrence	Phase 4
Completed	`NCT01743053` - A Pilot Trial of the Use of ReCell® Autologous Cell Harvesting Device for Venous Leg Ulcers	Phase 4
Recruiting	`NCT02312518` - A Prospective, Randomized Clinical Trial of PRP Concepts Fibrin Bio-Matrix in Chronic Non-Healing Venous Leg Ulcers	N/A
Recruiting	`NCT02352454` - Effectiveness of Aurix Therapy in Venous Leg Ulcers	N/A
Withdrawn	`NCT02940587` - Effectiveness of Aurix Therapy in Venous Leg Ulcers	Phase 4
Completed	`NCT01036438` - Evaluating the Efficacy of an Absorbent Foam Dressing Containing Silver (Mepilex Ag) Versus the Same Dressing Without Silver Used on Subjects With Venous Leg Ulcers or Mixed Ulcers	Phase 4
Completed	`NCT01656889` - Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers	Phase 3
Completed	`NCT02422017` - Topical Timolol Benefit in Venous Ulcers	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.